Ariel Soriano
Hematology & Oncology · Sidney, NENPI 1558345199
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $14,654 of the $20,104 with a category attached, or 72.9%. It is spread thinly across 28 manufacturers, the largest accounting for just 22.2%. Reporting peaked in 2020 at $7,879 and has fallen 97.0% since, to $237 in 2025.
Across 73 payments — averaging $275.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$4K
- Pfizer$3K
- Taiho Oncology, Inc.$3K
- AstraZeneca$3K
- Seagen Inc.$3K
- Sanofi$2K
- plus $2K from 22 others
What the payments were for
- Consulting fees$14,65473%
- Speaking & faculty fees$3,43017%
- Travel & lodging$3622%
- Food & beverage$1,3587%
- Education$3001%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 5 | $4,458 |
| Pfizer | 4 | $3,020 |
| Taiho Oncology, Inc. | 2 | $2,930 |
| AstraZeneca | 4 | $2,849 |
| Seagen Inc. | 7 | $2,799 |
| Sanofi | 1 | $1,924 |
| Daiichi Sankyo Inc. | 5 | $954 |
| Gilead | 5 | $306 |
| Astellas Pharma US Inc | 9 | $236 |
| Bayer | 3 | $69 |
| Merck | 3 | $67 |
| Johnson & Johnson | 4 | $63 |
| Angiodynamics, Inc. | 3 | $59 |
| Amgen | 2 | $54 |
| AVEO Pharmaceuticals, Inc. | 2 | $37 |
| Ipsen Biopharmaceuticals, Inc | 2 | $36 |
| Adaptive Biotechnologies Corporation | 1 | $29 |
| Myovant Sciences Inc. | 1 | $26 |
| Iovance Biotherapeutics, Inc. | 1 | $23 |
| Novartis | 1 | $23 |
| Teleflex LLC | 1 | $21 |
| Myriad Genetic Laboratories, Inc. | 1 | $20 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $20 |
| Sobi, Inc | 1 | $20 |
| Incyte Corporation | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
| Genentech USA, Inc. | 1 | $16 |
| Foundation Medicine, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$20,104 in reported general payments places this provider in the 75th percentile of 73 hematology & oncology providers in Nebraska.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Anastrozole | 34 | $327 |
| Hydroxyurea | 20 | $266 |
| Letrozole | 19 | $156 |
| Bicalutamide | 11 | $98 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Sidney
- Mojtaba AkhtariOmaha$1.8M
- Rabih FahedNorfolk$294K
- Luke NordquistOmaha$202K
- Apar Kishor GantiOmaha$138K
- Julie VoseOmaha$123K
- Peter SilbersteinOmaha$99K
- Krishna GundaboluOmaha$76K
- Vijaya BhattOmaha$58K
- Debora BrunoHastings$57K
- Pornchai JonglerthamHastings$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.